We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
426
STAAR Surgical
STAA
$1.14B
$725K 0.09%
+19,510
New +$728K
CLW icon
427
Clearwater Paper
CLW
$290M
$724K 0.09%
+25,381
New +$990K
CMCO icon
428
Columbus McKinnon
CMCO
$480M
$724K 0.09%
20,116
+5,256
+35% +$178K
SPOT icon
429
Spotify
SPOT
$106B
$722K 0.09%
1,960
-5,262
-73% -$1.75M
OLED icon
430
Universal Display
OLED
$3.84B
$721K 0.09%
+3,434
New +$696K
BC icon
431
Brunswick
BC
$5.38B
$720K 0.09%
8,592
-3,124
-27% -$243K
ZBH icon
432
Zimmer Biomet
ZBH
$18.6B
$720K 0.09%
+6,670
New +$728K
CCC
433
CCC Intelligent Solutions
CCC
$3.6B
$716K 0.09%
64,812
+36,391
+128% +$393K
AAMI
434
Acadian Asset Management
AAMI
$2.96B
$716K 0.09%
+28,192
New +$676K
EPR icon
435
EPR Properties
EPR
$4.92B
$716K 0.09%
14,592
-30,803
-68% -$1.41M
BSX icon
436
Boston Scientific
BSX
$69.1B
$715K 0.09%
+8,535
New +$673K
PCH
437
DELISTED
PotlatchDeltic
PCH
$713K 0.09%
+15,835
New +$671K
GGG icon
438
Graco
GGG
$13.4B
$710K 0.08%
+8,110
New +$665K
CAMT icon
439
Camtek
CAMT
$6.53B
$707K 0.08%
+8,856
New +$863K
CBL
440
CBL Properties
CBL
$1.85B
$702K 0.08%
+27,869
New +$708K
ALG icon
441
Alamo Group
ALG
$2.02B
$700K 0.08%
3,886
-2,617
-40% -$467K
WFRD icon
442
Weatherford International
WFRD
$6.08B
$699K 0.08%
+8,234
New +$887K
JACK icon
443
Jack in the Box
JACK
$312M
$698K 0.08%
15,002
+9,339
+165% +$469K
FLR icon
444
Fluor
FLR
$6.88B
$694K 0.08%
+14,554
New +$686K
EXPD icon
445
Expeditors International
EXPD
$22.4B
$694K 0.08%
5,282
-6,078
-54% -$744K
CNP icon
446
CenterPoint Energy
CNP
$29.1B
$688K 0.08%
+23,399
New +$655K
FTAI icon
447
FTAI Aviation
FTAI
$21.3B
$688K 0.08%
+5,174
New +$586K
BKD icon
448
Brookdale Senior Living
BKD
$3.66B
$687K 0.08%
+101,167
New +$722K
JBSS icon
449
John B. Sanfilippo & Son
JBSS
$998M
$685K 0.08%
7,265
-892
-11% -$86.4K
RGEN icon
450
Repligen
RGEN
$8.53B
$685K 0.08%
+4,603
New +$660K
16 17
18
19 20

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.